Foundayo vs. Wegovy tablets: comparing the new GLP-1 pills

A brand-new oral GLP-1 just got FDA-approved in March 2026 — and it could be a game-changer for people who hate the strict rules of Wegovy (Semaglutide) tablets. In this pharmacist-led head-to-head comparison, I break down FOUNDAYO (orforglipron) vs Wegovy oral tablets: the real differences in how they work, dosing flexibility, side effects, and the one important warning almost nobody is talking about yet.

• What you’ll learn:
• The fundamental chemistry difference (non-peptide vs peptide) that changes everything about daily use
• No-food-restrictions vs empty-stomach-only dosing — which is easier in real life?
• Head-to-head comparison: weight loss results, half-life, approvals, and more
• Side effects to expect + the surprising dysesthesia and birth control interaction with FOUNDAYO
• Practical pharmacist advice: who might do better on FOUNDAYO vs Wegovy tablets